JAK-STAT Control of Zika Virus-Induced Fetal Injury

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3R01AI143265-02S1

Grant search

Key facts

  • Disease

    Zika virus disease
  • Start & end year

    2021
    2021
  • Known Financial Commitments (USD)

    $328,382
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    PROFESSOR KRISTINA ADAMS WALDORF
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF WASHINGTON
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Project Summary The current project, "Jak STAT control of Zika virus-induced fetal injury" (R01 AI143265), includes the processing of many nonhuman primate (NHP) and human tissue and cell samples for high throughput RNA sequencing (RNAseq) analysis. Our sample-processing pipeline for these assays includes RNA isolation and quality control (QC), and library construction and library QC. We currently utilize a Biomek FX automated workstation to perform the majority of these work steps in handling high volume samples in our high throughput workload for these analyses. The Biomek FX is 10 years old. Due to the age, it is not reliable, the ability to obtain a future service contract is not guaranteed, and the current configuration and software are not compatible with off- the-shelf protocols. Thus, we are in need of funds to replace this instrument. The purchase of a Biomek i7 Hybrid automated workstation to replace our Biomek FX workstation, allows us to achieve our stated project goals. 0